406 related articles for article (PubMed ID: 18384182)
1. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Sharma U; Danishad KK; Seenu V; Jagannathan NR
NMR Biomed; 2009 Jan; 22(1):104-13. PubMed ID: 18384182
[TBL] [Abstract][Full Text] [Related]
2. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
3. Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI).
Danishad KK; Sharma U; Sah RG; Seenu V; Parshad R; Jagannathan NR
NMR Biomed; 2010 Apr; 23(3):233-41. PubMed ID: 20175134
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T.
Lo GG; Ai V; Chan JK; Li KW; Cheung PS; Wong TT; Ma M; Lee R; Chien D
J Comput Assist Tomogr; 2009; 33(1):63-9. PubMed ID: 19188787
[TBL] [Abstract][Full Text] [Related]
5. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy.
Pickles MD; Lowry M; Manton DJ; Gibbs P; Turnbull LW
Breast Cancer Res Treat; 2005 May; 91(1):1-10. PubMed ID: 15868426
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment.
Belli P; Costantini M; Ierardi C; Bufi E; Amato D; Mule' A; Nardone L; Terribile D; Bonomo L
Breast J; 2011; 17(6):610-9. PubMed ID: 21929557
[TBL] [Abstract][Full Text] [Related]
7. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
Jung SH; Heo SH; Kim JW; Jeong YY; Shin SS; Soung MG; Kim HR; Kang HK
J Magn Reson Imaging; 2012 Jan; 35(1):110-6. PubMed ID: 21989997
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients.
Jensen LR; Garzon B; Heldahl MG; Bathen TF; Lundgren S; Gribbestad IS
J Magn Reson Imaging; 2011 Nov; 34(5):1099-109. PubMed ID: 22002757
[TBL] [Abstract][Full Text] [Related]
9. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
[TBL] [Abstract][Full Text] [Related]
10. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
[TBL] [Abstract][Full Text] [Related]
11. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer.
Pickles MD; Gibbs P; Lowry M; Turnbull LW
Magn Reson Imaging; 2006 Sep; 24(7):843-7. PubMed ID: 16916701
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
13. Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study.
Kumar M; Jagannathan NR; Seenu V; Dwivedi SN; Julka PK; Rath GK
J Magn Reson Imaging; 2006 Aug; 24(2):325-32. PubMed ID: 16786567
[TBL] [Abstract][Full Text] [Related]
14. Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS.
Shin HJ; Baek HM; Ahn JH; Baek S; Kim H; Cha JH; Kim HH
NMR Biomed; 2012 Dec; 25(12):1349-59. PubMed ID: 22566277
[TBL] [Abstract][Full Text] [Related]
15. Quantitative diffusion-weighted magnetic resonance imaging of normal and diseased uterine zones.
Kilickesmez O; Bayramoglu S; Inci E; Cimilli T; Kayhan A
Acta Radiol; 2009 Apr; 50(3):340-7. PubMed ID: 19235579
[TBL] [Abstract][Full Text] [Related]
16. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors.
Kim SH; Cha ES; Kim HS; Kang BJ; Choi JJ; Jung JH; Park YG; Suh YJ
J Magn Reson Imaging; 2009 Sep; 30(3):615-20. PubMed ID: 19711411
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
[TBL] [Abstract][Full Text] [Related]
19. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy.
Yu HJ; Chen JH; Mehta RS; Nalcioglu O; Su MY
J Magn Reson Imaging; 2007 Sep; 26(3):615-23. PubMed ID: 17729334
[TBL] [Abstract][Full Text] [Related]
20. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer.
Kim YC; Lim JS; Keum KC; Kim KA; Myoung S; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW
J Magn Reson Imaging; 2011 Sep; 34(3):570-6. PubMed ID: 21751285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
